Back

ReCOGnAIze app to detect mild cognitive impairment and vascular cognitive impairment

Mohammed, A. A.; Vipin, A.; Jin, L. Y.; Setiabudi, E.; Tan, F.; Agarwal, H.; Liau, K. X.; Tanoto, P.; Liew, S. Y.; Qiu, B.; Sandhu, G. K.; Wang, J. D. J.; Aravindhan, K.; Kandiah, N.

2025-05-11 neurology
10.1101/2025.05.10.25327352 medRxiv
Show abstract

INTRODUCTIONMild Cognitive Impairment (MCI) is underdiagnosed due to subtle symptoms. Vascular Cognitive Impairment (VCI), the second leading cause of cognitive impairment, remains underdiagnosed due to varying non-amnestic manifestations. We aimed to develop and validate ReCOGnAIze, a gamified, interpretable digital app to detect MCI and VCI. METHODSA multi-phase, cross sectional study in an Asian community cohort with development phase (n=200) and validation with 235 independent participants having comprehensive neuroimaging and neuropsychological data. RESULTSIn 235 subjects, ReCOGnAIze composite score accurately distinguished MCI from cognitively normal individuals (AUC = 0.90), outperforming the Montreal Cognitive Assessment (AUC = 0.70). For VCI detection, it achieved strong performance (n = 155; Average AUC = 0.85), identifying biomarkers of VCI; response time variability, task efficiency, consistent with known cerebrovascular disease impairments. DISCUSSIONReCOGnAIze is a scalable, explainable AI tool that accurately detects MCI and VCI, with interpretable clinical insights.

Published in Alzheimer's & Dementia · not in our set (fewer than 10 published preprints to learn from) · training set

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.